These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 894203)

  • 1. A simplified micromethod for the determination of the acetylator phenotype.
    Hoo JJ; Hussein L; Goedde HW
    J Clin Chem Clin Biochem; 1977 Jun; 15(6):329-31. PubMed ID: 894203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation of sulfamethazine in a Nigerian population.
    Eze LC; Obidoa O
    Biochem Genet; 1978 Dec; 16(11-12):1073-7. PubMed ID: 751642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetylation phenotyping with sulphadimidine in a Turkish population.
    Bozkurt A; Basci NE; Kalan S; Tuncer M; Kayaalp SO
    Eur J Clin Pharmacol; 1990; 38(1):53-6. PubMed ID: 2328748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the sulphadimidine acetylator phenotyping test in patients with reduced renal function.
    Hall S
    Acta Med Scand; 1981; 209(6):505-7. PubMed ID: 7257867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between acetylator phenotype and intensity of the hypoglycaemic effect of a suplhonamide preparation in children with insulin-dependent diabetes.
    Hadasová E; Brysová V; Utĕsený J; Macků M
    Bratisl Lek Listy; 1991 Dec; 92(12):609-14. PubMed ID: 1806177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible optimization of sulphadimidine dosage for acetylator phenotyping.
    Hombhanje F
    Jpn J Pharmacol; 1991 Aug; 56(4):531-4. PubMed ID: 1744992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the acetylator phenotype in a Northern Nigerian population.
    Fawcett IW; Gammon PT
    Tubercle; 1975 Sep; 56(3):199-201. PubMed ID: 1216338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetylation phenotyping with sulfamethazine in an Iranian population.
    Sardaş S; Lahijany B; Cok I; Karakaya AE
    Pharmacogenetics; 1993 Jun; 3(3):131-4. PubMed ID: 8334437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic discrimination of three sulfamethazine acetylation phenotypes.
    Chapron DJ; Kramer PA; Mercik SA
    Clin Pharmacol Ther; 1980 Jan; 27(1):104-13. PubMed ID: 7351110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acetaminophen on sulfamethazine acetylation in male volunteers.
    Tahir IM; Iqbal T; Saleem S; Mehboob H; Akhter N; Riaz M
    Int J Immunopathol Pharmacol; 2016 Mar; 29(1):17-22. PubMed ID: 26519524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening methods using sulfamethazine for determining acetylator phenotype.
    du Souich P; McLean AJ; Stoeckel K; Ohlendorf D; Gibaldi M
    Clin Pharmacol Ther; 1979 Dec; 26(6):757-65. PubMed ID: 498718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonazepam acetylation in fast and slow acetylators.
    Miller ME; Garland WA; Min BH; Ludwick BT; Ballard RH; Levy RH
    Clin Pharmacol Ther; 1981 Sep; 30(3):343-7. PubMed ID: 7273597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent changes in sulfamethazine kinetics in rapid and slow isoniazid acetylators.
    Olson W; Miceli J; Weber W
    Clin Pharmacol Ther; 1978 Feb; 23(2):204-11. PubMed ID: 620482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of the slow acetylator phenotype with bladder cancer.
    Evans DA; Eze LC; Whibley EJ
    J Med Genet; 1983 Oct; 20(5):330-3. PubMed ID: 6644762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphic N-acetylation of sulfamethazine and benzidine by human liver: implication for cancer risk?
    Peters JH; Gordon GR; Lin E; Green CE; Tyson CA
    Anticancer Res; 1990; 10(1):225-9. PubMed ID: 2334132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylator polymorphism in rheumatoid arthritis.
    Ladero JM; Andres MP; Bañares A; Fernández B; Hernández C; Benítez J
    Eur J Clin Pharmacol; 1993; 45(3):279-81. PubMed ID: 8276055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological evidence for N-acetyltransferase isozymes in the rabbit.
    Reeves PT; Kinnear BF; Minchin RF; Ilett KF
    Mol Pharmacol; 1991 Jan; 39(1):42-8. PubMed ID: 1987451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylator phenotype in psoriasis.
    Jiménez-Nieto LC; Ladero JM; Fernández-Gundín MJ; Robledo A
    Dermatologica; 1989; 178(3):136-7. PubMed ID: 2721804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
    Singh SP; Pande JN; Khilnani GC; Kailash S
    Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.